Cervical Cancer Screening Market, 2026 - Patients, Mortality Forecast by Tests Type -Pap Smear, HPV DNA, VIA
February 08, 2021 04:18 ET
|
Research and Markets
Dublin, Feb. 08, 2021 (GLOBE NEWSWIRE) -- The "Cervical Cancer Screening Market, Patients, Mortality Global Forecast by Tests Type (Pap Smear, HPV DNA, VIA), 19 Countries Analysis" report has been...
Global Cervical Cancer Diagnostic Testing Devices Pipeline Assessment 2020: Developments, Products, Company Product Overview, Recent Developments
December 24, 2020 05:18 ET
|
Research and Markets
Dublin, Dec. 24, 2020 (GLOBE NEWSWIRE) -- The "Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" report has been added to ResearchAndMarkets.com's offering. "Cervical...
Global Cervical Cancer Diagnostics Market Report 2020: Market is Expected to Recover and Reach $8.62 Billion in 2023 at a CAGR of 6.04%
December 22, 2020 05:58 ET
|
Research and Markets
Dublin, Dec. 22, 2020 (GLOBE NEWSWIRE) -- The "Cervical Cancer Diagnostics Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering. ...
Atossa Genetics Signs Distribution Agreement With Fisher HealthCare
June 20, 2013 08:00 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Jun 20, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, has signed an agreement with Fisher HealthCare Inc., part of Thermo Fisher...
Atossa Genetics Supports Are You Dense, Inc. and Its Work to Enact Dense Breast Notification Laws
June 10, 2013 08:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Jun 10, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, today announced its support for Are You Dense, Inc., an independent, national...